We are live on ! Find out more
IPC

Invesco Private Capital Portfolio holdings

AUM $365M
1-Year Est. Return 8.08%
This Fund
S&P 500
This Quarter Est. Return
-26.15%
1 Year Est. Return
-8.08%
3 Year Est. Return
+41.89%
5 Year Est. Return
-16.05%
10 Year Est. Return
–
AUM
$297M
AUM Growth
-$230M
Cap. Flow
-$88.5M
Cap. Flow %
-29.85%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CACB
Cascade Bancorp
CACB
+$88.5M
2
XENE icon
Xenon Pharmaceuticals
XENE
+$19.5K

Sector Composition

Rank Sector Weight
1 Energy 64.23%
2 Financials 35.37%
3 Healthcare 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVGS icon
1
Navigator Holdings
NVGS
$1.36B
$181M 61.19%
21,863,874
– –
SNBC
2
DELISTED
Sun Bancorp Inc
SNBC
$105M 35.37%
4,255,848
– –
XCO
3
DELISTED
Exco Resources
XCO
$9.03M 3.04%
3,406,937
– –
XENE icon
4
Xenon Pharmaceuticals
XENE
$5.81B
$1.18M 0.4%
375,784
-5,000
-1% -$19.5K
CACB
5
DELISTED
Cascade Bancorp
CACB
– –
-11,478,529
Closed -$88.5M

Similar funds

AEPG
American Economic Planning Group Warren, New Jersey $367M AUM 2.51% 1-Year Est. Return
AR
Argyll Research Wilmington, Delaware $377M AUM 4.86% 1-Year Est. Return
LCM
Lucha Capital Management San Francisco, California $327M AUM 2.87% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
COI
Capital One Investing Mclean, Virginia $430M AUM 3.49% 1-Year Est. Return
GWA
Guidant Wealth Advisors Palatine, Illinois $269M AUM 0.85% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return

Invesco Private Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Invesco Private Capital held 5 positions worth $297M, down 44% from $526M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Invesco Private Capital withdrew a net $88.5M in Q2 2017, closing 1 position and reducing 1 holding. Its most notable exit was Cascade Bancorp, an estimated $88.5M position sold in full.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 63% a quarter earlier, followed by Financials and Healthcare.

  • Invesco Private Capital's biggest Q2 2017 reduction was Xenon Pharmaceuticals, cutting an estimated $19.5K.
  • Invesco Private Capital fully exited Cascade Bancorp in Q2 2017, selling an estimated $88.5M.
  • Invesco Private Capital's ten largest holdings make up 100% of its $297M portfolio in Q2 2017.
  • Invesco Private Capital opened 0 new positions and closed 1 in Q2 2017.
  • Invesco Private Capital's portfolio value fell 44% quarter-over-quarter to $297M.

Based on Invesco Private Capital's 13F filing for Q2 2017, filed 14 Aug 2017.